SPOTRX
MedAvail, Inc.
Mark For: SPOTRX™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88166516 |
| Mark Literal Elements | SPOTRX |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED 2020-10-21 |
| Basis | 1(b) 44(d) 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michael T. Olsen |
| Attorney Docket Number | 21817.1 |
| Law Office Assigned | N90 |
| Employee Name | KOBERIDZE, MARYNA |
Timeline
| 2018-10-23 | Application Filed |
| 2019-09-12 | Location: TMO LAW OFFICE 127 |
| 2019-09-12 | Status: Live/Pending |
| 2019-09-12 | Transaction Date |
| 2020-10-21 | Location: TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED |
| 2020-10-21 | Status: An Office action suspending further action on the application has been sent (issued) to the applicant. To view all documents in |
Trademark Parties (Applicants & Owners)
| Party: |  MedAvail, Inc. |
| Address | 251 Little Falls Drive Wilmington, DELAWARE UNITED STATES 19808 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2018-10-23 |
 TEAS RF New Application | MULTI | 2018-10-23 |
| XSearch Search Summary | XML | 2019-02-04 |
| Suspension Letter | MULTI | 2019-02-05 |
| Offc Action Outgoing | MULTI | 2020-04-21 |
| Response to Office Action | XML | 2020-10-14 |
| Suspension Letter | XML | 2020-10-21 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-10-22 |
Attorney of Record
Good, Services, and Codes
IC 039. US 100 105. G & S: Home delivery of prescription and non-prescription pharmaceuticals, drugs and medications; Delivery of prescription and non-prescription pharmaceuticals, drugs and medications
| International Codes: | 39 |
| U.S. Codes: | 100,105 |
| Type Code | Type |
|---|---|
| GS0391 | Home delivery of prescription and non-prescription pharmaceuticals, drugs and medications; Delivery of prescription and non-prescription pharmaceuticals, drugs and medications |
| GS0391 | Home delivery of prescription and non-prescription pharmaceuticals, drugs and medications; Delivery of prescription and non-prescription pharmaceuticals, drugs and medications |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-10-21 | 73296 |
| SUSPENSION LETTER WRITTEN | 2020-10-21 | 94372 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2020-10-21 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2020-10-21 | 6332 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-10-21 | 73296 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-10-14 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-04-21 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-04-21 | 94372 |
| NON-FINAL ACTION E-MAILED | 2020-04-21 | 6325 |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2020-04-02 | 73296 |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2019-09-12 | 73296 |
| ASSIGNED TO LIE | 2019-09-12 | 73296 |
| SUSPENSION LETTER WRITTEN | 2019-02-05 | 94372 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-02-05 | 6332 |
| LETTER OF SUSPENSION E-MAILED | 2019-02-05 | 6332 |
| ASSIGNED TO EXAMINER | 2019-01-30 | 94372 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-05 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-10-26 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 